A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection (Q36975397)

17 August 2017

A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection (English)

1 reference

17 August 2017

Jintanat Ananworanich

1

object named as

Jintanat Ananworanich

1 reference

17 August 2017

14

Praphan Phanuphak

1 reference

17 August 2017

Pope Kosalaraksa

2

1 reference

17 August 2017

Umaporn Siangphoe

3

1 reference

17 August 2017

Chulapan Engchanil

4

1 reference

17 August 2017

Chitsanu Pancharoen

5

1 reference

17 August 2017

Pagakrong Lumbiganon

6

1 reference

17 August 2017

Jintana Intasan

7

1 reference

17 August 2017

Wichitra Apateerapong

8

1 reference

17 August 2017

Theshinee Chuenyam

9

1 reference

17 August 2017

Sasiwimol Ubolyam

10

1 reference

17 August 2017

Torsak Bunupuradah

11

1 reference

17 August 2017

Joep Lange

12

1 reference

17 August 2017

David A Cooper

13

1 reference

17 August 2017

HIV-NAT 010 Study Team

15

1 reference

17 August 2017

language of work or name

1 reference

28 October 2008

1 reference

AIDS Research and Therapy

17 August 2017

1 reference

17 August 2017

5

1 reference

17 August 2017

24

1 reference

https://scigraph.springernature.com/pub.10.1186/1742-6405-5-24

17 August 2017

0 references

cites work

Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

Impact of long-term viral suppression in CD4+ recovery of HIV-children on Highly Active Antiretroviral Therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected children

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

Metabolic complications of HIV therapy in children.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

PENTA guidelines for the use of antiretroviral therapy, 2004.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobuli

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584102

Antiretroviral Treatment in Pediatric HIV Infection in the United States From Clinical Trials to Clinical Practice

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1742-6405-5-24

Guidelines for the use of antiretroviral agents in pediatric HIV infection. Center for Disease Control and Prevention

21 January 2018

1 reference

12 December 2020

High CD4+ T-cells percentage and/or low viral load are predictors of 1-5 years survival in HIV-1 vertically infected Thai children

1 reference

12 December 2020

Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children

1 reference

12 December 2020

Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee

1 reference

12 December 2020

Identifiers

DOI

10.1186/1742-6405-5-24

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference

17 August 2017

PubMed publication ID

18957095

1 reference